Shlomo Melmed, MB, ChB, FRCP, MACP, is Executive VP and Dean of the Medical Faculty at Cedars-Sinai Medical Center. He leads Cedars-Sinai's research and education programs, recruiting nationally recognized faculty leadership, establishing new educational programs and maintaining the highest academic standards. Dr. Melmed holds the Helene A. and Philip E. Hixon Distinguished Chair in Investigative Medicine. An international authority on pituitary medicine, he has pioneered the discovery and application of novel treatments for endocrine tumors and has authored more than 350 peer-reviewed articles.Dr. Melmed has been a faculty leader at Cedars-Sinai for nearly 40 years and has been the health system's chief academic officer since 1998. Dr. Melmed's laboratory consistently has received competitive grant awards from the National Institutes of Health since 1980, and he has trained over 80 physicians, scientists and graduate students who occupy leading positions in academic endocrinology worldwide. He is on the editorial board of the Journal of Clinical Investigation and is also an Associate Dean of the UCLA School of Medicine.

• Development of the PituitaryProlactinAdrenocotricotropic HormoneEndocrine Rhythms, The Sleep-Wake Cycle, and Biological ClocksHypothalamic SyndromesHypopituitarism and Growth Hormone DeficiencyAcromegalyCushing's SyndromeClinically Nonfunctioning Sellar MassesTsh-Producing AdenomasDisorders of Prolactin Secretion and ProlactinomasPituitary SurgeryEvaluation and Management of Childhood Hypothalamic and Pituitary TumorsVasopressin, Diabetes Insipidus, and the Syndrome of Inappropriate Antidiuretic Hormone SecretionThe Pineal Gland and MelatoninRegulation of Growth Hormone and Action (Secretagogues)Insulin-like Growth Factor-1 and its Binding ProteinsSomatic Growth and MaturationGrowth Hormone Deficiency in Children

Shlomo Melmed, MB, ChB, FRCP, MACP, is Executive VP and Dean of the Medical Faculty at Cedars-Sinai Medical Center. He leads Cedars-Sinai's research and education programs, recruiting nationally recognized faculty leadership, establishing new educational programs and maintaining the highest academic standards. Dr. Melmed holds the Helene A. and Philip E. Hixon Distinguished Chair in Investigative Medicine. An international authority on pituitary medicine, he has pioneered the discovery and application of novel treatments for endocrine tumors and has authored more than 350 peer-reviewed articles.Dr. Melmed has been a faculty leader at Cedars-Sinai for nearly 40 years and has been the health system's chief academic officer since 1998. Dr. Melmed's laboratory consistently has received competitive grant awards from the National Institutes of Health since 1980, and he has trained over 80 physicians, scientists and graduate students who occupy leading positions in academic endocrinology worldwide. He is on the editorial board of the Journal of Clinical Investigation and is also an Associate Dean of the UCLA School of Medicine.

• Development of the PituitaryProlactinAdrenocotricotropic HormoneEndocrine Rhythms, The Sleep-Wake Cycle, and Biological ClocksHypothalamic SyndromesHypopituitarism and Growth Hormone DeficiencyAcromegalyCushing's SyndromeClinically Nonfunctioning Sellar MassesTsh-Producing AdenomasDisorders of Prolactin Secretion and ProlactinomasPituitary SurgeryEvaluation and Management of Childhood Hypothalamic and Pituitary TumorsVasopressin, Diabetes Insipidus, and the Syndrome of Inappropriate Antidiuretic Hormone SecretionThe Pineal Gland and MelatoninRegulation of Growth Hormone and Action (Secretagogues)Insulin-like Growth Factor-1 and its Binding ProteinsSomatic Growth and MaturationGrowth Hormone Deficiency in Children

Shlomo Melmed, MB, ChB, FRCP, MACP, is Executive VP and Dean of the Medical Faculty at Cedars-Sinai Medical Center. He leads Cedars-Sinai's research and education programs, recruiting nationally recognized faculty leadership, establishing new educational programs and maintaining the highest academic standards. Dr. Melmed holds the Helene A. and Philip E. Hixon Distinguished Chair in Investigative Medicine. An international authority on pituitary medicine, he has pioneered the discovery and application of novel treatments for endocrine tumors and has authored more than 350 peer-reviewed articles.Dr. Melmed has been a faculty leader at Cedars-Sinai for nearly 40 years and has been the health system's chief academic officer since 1998. Dr. Melmed's laboratory consistently has received competitive grant awards from the National Institutes of Health since 1980, and he has trained over 80 physicians, scientists and graduate students who occupy leading positions in academic endocrinology worldwide. He is on the editorial board of the Journal of Clinical Investigation and is also an Associate Dean of the UCLA School of Medicine.

• Development of the PituitaryProlactinAdrenocotricotropic HormoneEndocrine Rhythms, The Sleep-Wake Cycle, and Biological ClocksHypothalamic SyndromesHypopituitarism and Growth Hormone DeficiencyAcromegalyCushing's SyndromeClinically Nonfunctioning Sellar MassesTsh-Producing AdenomasDisorders of Prolactin Secretion and ProlactinomasPituitary SurgeryEvaluation and Management of Childhood Hypothalamic and Pituitary TumorsVasopressin, Diabetes Insipidus, and the Syndrome of Inappropriate Antidiuretic Hormone SecretionThe Pineal Gland and MelatoninRegulation of Growth Hormone and Action (Secretagogues)Insulin-like Growth Factor-1 and its Binding ProteinsSomatic Growth and MaturationGrowth Hormone Deficiency in Children